New technology developed by German researchers allows existing traditional scanners to be used to generate high-resolution images of tumour vasculature by analysing ultrasound images.

Led by Dr Georg Schmitz from Ruhr-Universität Bochum and Dr Fabian Kiessling at the University Hospital Aachen, the new Motion Model Ultrasound Localization Microscopy is designed to easily differentiate tumour types.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

In addition, the technique can be used to track the progress of chemotherapy treatment.

Based on contrast medium-enhanced ultrasound, the approach involves the administration of microbubbles that can travel in the bloodstream that appear as ‘shapeless white blobs’ in ultrasound images.

“The technology uses algorithms to track the motion of the individual microbubbles, allowing researchers to monitor their journey through the blood vessels and count them.”

The technology uses algorithms to track the motion of the individual microbubbles, allowing researchers to monitor their journey through the blood vessels and count them.

Schmitz said: “We are currently attempting to teach the computer something that our eyes are able to do: namely read movement in a sequence of images in which a dot appears in different locations.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

According to the researchers, their motion also allows for fine vascular networks to be reconstructed, as well as the recording of direction and speed of blood flow.

When tested in three models, including one human subject, the technology is capable of monitoring the response of tumour vessels to chemotherapy in patients with breast cancer.

Kiessling said: “One reason why this is important is because new therapy approaches aim at manipulating the vascular system of tumours, in order to enhance the therapeutic effect by increasing the concentration of drugs in the tumours.”

While the technology is yet to be validated in large clinical studies, researchers believe it can be used even with standard ultrasound scanners with a low frame frequency.

 

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact